Pathstone Family Office’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $988K | Buy |
6,686
+2,186
| +49% | +$323K | 0.01% | 709 |
|
|
2023
Q2 | $1.11M | Buy |
4,500
+1,551
| +53% | +$384K | 0.02% | 448 |
|
|
2023
Q1 | $611K | Sell |
2,949
-16,421
| -85% | -$3.4M | 0.01% | 606 |
|
|
2022
Q4 | $3.03M | Buy |
19,370
+5,347
| +38% | +$836K | 0.03% | 389 |
|
|
2022
Q3 | $3.06M | Buy |
14,023
+12,752
| +1,003% | +$2.78M | 0.03% | 318 |
|
|
2022
Q2 | $266K | Buy |
1,271
+718
| +130% | +$150K | 0.01% | 848 |
|
|
2022
Q1 | $490K | Buy |
+553
| New | +$490K | 0.01% | 557 |
|
|
2021
Q1 | – | Sell |
-252
| Closed | -$53K | – | 1184 |
|
|
2020
Q4 | $53K | Buy |
+252
| New | +$53K | ﹤0.01% | 503 |
|
|
2018
Q2 | – | Sell |
-21
| Closed | -$2K | – | 296 |
|
|
2018
Q1 | $2K | Buy |
+21
| New | +$2K | ﹤0.01% | 336 |
|